Drug Prices
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit
Drug Prices
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit

How Do Patients and Providers Feel About Drug Costs in Medicare?
Drug Prices
How Do Patients and Providers Feel About Drug Costs in Medicare?

AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Drug Prices
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan

Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Drug Prices
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Drug Prices
AV Submits Letter on Controlled Clinical Investigation and Confirmatory Evidence

23 Stories of Transformative Policymaking from 2023
Policing
23 Stories of Transformative Policymaking from 2023
Year in Review
Drug Prices
AV Submits Letter on Excise Tax on Designated Drugs

In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
Drug Prices
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment

How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
AV Submits Letter on Decentralized Clinical Trials
Drug Prices
AV Submits Formal Comments for Proposed Rule on Drug Rebate Program
Drug Prices
How Policymakers Can Fix Pharmacy Benefit Managers

State by State, Lawmakers Aim at Affordable Prescriptions for All
Drug Prices
State by State, Lawmakers Aim at Affordable Prescriptions for All

3 Evidence-Based Reasons Medicare Negotiation Makes Sense
Drug Prices
3 Evidence-Based Reasons Medicare Negotiation Makes Sense

Landmark Drug Pricing Reforms Moving Forward
Drug Prices
Landmark Drug Pricing Reforms Moving Forward

5 Things to Watch in 2023 in Health Care
Drug Prices
5 Things to Watch in 2023 in Health Care
Look Ahead

5 Big Wins in 2022 for Health Care
Drug Prices
5 Big Wins in 2022 for Health Care
2022 Year in Review

About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.